Learn More
Selleck Chemical LLC Amredobresib E4609-100MG

Supplier: Selleck Chemical LLC E4609100MG
Amredobresib (BI894999) is an oral inhibitor of BET which acts as an acetyl-lysine mimic It prevents the bromodomains BRD4-BD1 and BRD4-BD2 from binding to acetylated histones with an IC50 of 5 nM for BRD4-BD1 and 41 nM for BRD4-BD2
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.